Rocket Lab ($RKLB): 98 Electron Launches, Neutron Debut Moved to 2027, Iridium Still Pending

01 The operating case and three possible outcomes

Rocket Lab has won another large commitment from a repeat launch customer while preparing a much larger change to its business. Rocket Lab’s September 30, 2026 announcement (October 1 in Japan) covers twenty additional dedicated Electron launches for Synspective during 2028–2031. That is contracted future work for an established rocket, although none of those launches falls in 2026 or 2027. The proposed acquisition of Iridium would add a satellite communications operator, but remains subject to regulatory conditions after the shareholder vote on September 24, 2026. Neutron occupies a third category: a development programme whose commercial potential depends on completing qualification and showing reliable flight operations. These three developments have different timetables and different financial consequences. Synspective announcement Iridium voting results Quarterly report

The financial foundation is a growing manufacturing and launch group that still consumes cash. For the quarter ended June 30, 2026, Rocket Lab reported revenue of $234.066 million and a GAAP net loss of $49.258 million. Operating activities used $134.407 million during the six months ended on that date. The September financing announcement subsequently disclosed substantial new equity proceeds, which strengthen funding capacity while increasing the number of shares among which future earnings must be divided. Quarterly report September financing filing

Bull case

Electron converts repeat commercial orders into dependable launches, while Space Systems turns its manufacturing backlog into accepted hardware and collected cash. The Synspective agreement supports that case because it extends a relationship with demonstrated delivery history. Neutron completes its remaining engineering work and develops a commercial cadence, rather than stopping at a successful demonstration. Iridium receives the required clearances, closes on acceptable terms and adds recurring service revenue without consuming disproportionate management attention or capital. The evidence would be improving operating margins and cash conversion alongside deliveries, with growth becoming less dependent on acquired revenue and repeated share issuance.

This outcome does not require treating every announced contract ceiling as firm revenue. It requires execution on enforceable work, retention of customers and control over manufacturing costs. A healthy order book can support investments in people, tooling and suppliers; those investments become economically valuable only if the resulting products earn enough to cover both their own costs and the group’s development spending. The relevant comparison is growth in earning power per share after financing and integration costs.

Base case

Demand remains strong but progress is uneven. Launch scheduling and manufacturing milestones shift revenue between quarters; recently acquired operations require further spending; Neutron advances through testing without a perfectly linear timetable. The Iridium process continues through regulatory review, with its benefits still prospective. Rocket Lab uses the capital already raised to sustain several programmes simultaneously, while GAAP losses and working-capital needs remain meaningful. This would describe an expanding industrial company still building its economic model, rather than a business that has already reached self-funded profitability.

Bear case

Customer schedules slip, fixed-price manufacturing costs rise or a launch interruption delays multiple missions. Neutron requires more time and cash than expected, while the acquisition programme adds operational complexity. Iridium could be delayed, face restrictive conditions or fail to close; even after closing, integration and constellation investment could absorb more resources than anticipated. Shareholders would then have financed expansion before receiving the intended earnings benefit. Rocket Lab’s annual and quarterly risk disclosures identify these mechanisms, including customer concentration, contract cancellation, cost overruns and development uncertainty. The scenarios are analytical possibilities, without assigned probabilities or share-price targets. Annual report Quarterly report

What Would Falsify This Reading

The operating case needs durable demand, funded delivery and improving cash conversion.

• Repeat-customer execution breaks down. Cancellations or prolonged launch interruptions would weaken the interpretation of a dependable commercial launch franchise.
• Manufacturing growth fails to become cash. Persistently slower collections, adverse cost revisions and rising working capital would weaken the quality of reported growth.
• Capital commitments outpace operating progress. Development delays or acquisition obligations without improving earning power per share would undermine the case for the expanded business.

These are observations that would weaken the interpretation, not forecasts of inevitable events.

02 What Rocket Lab sells and why the mix matters

Rocket Lab combines launch services with spacecraft manufacturing, components, software and mission operations. Electron provides dedicated access to orbit for small spacecraft. HASTE adapts that heritage to suborbital testing. Neutron is intended to address larger payloads and constellation deployment, but remains a development programme in the August 10, 2026 quarterly filing. Space Systems encompasses spacecraft platforms and components such as solar-power hardware, reaction wheels, star trackers, separation systems, optical payloads and flight software. The business can sell individual parts, an assembled spacecraft or a wider mission package. Annual report Quarterly report

That breadth changes how a customer relationship works. A spacecraft manufacturer can buy Rocket Lab components without selecting its launch vehicle. A launch customer can require a precise orbit and a dedicated schedule without buying the spacecraft from Rocket Lab. An integrated mission may involve several capabilities together. Vertical integration can reduce coordination between suppliers and retain more contract value within the group, but also requires Rocket Lab to fund and manage more stages of production. Internal supply capability does not eliminate outside vendors, export controls or qualification requirements.

The reported mix makes this more than a conceptual distinction. Space Systems supplied $189.480 million of the $234.066 million of revenue reported for the quarter ended June 30, 2026, while Launch Services supplied $44.586 million. The resulting Space Systems share is approximately 81%, calculated from the quarterly segment table. A description of Rocket Lab based only on how many rockets launch therefore misses most of the revenue base in that period. Conversely, the launch business remains strategically important because it supplies operating experience, customer access and part of the appeal of an integrated mission offering. Quarterly report

The strategy also exposes different kinds of execution risk. A launch can generate a discrete completion event; spacecraft production can span many reporting periods. Component shortages can delay deliveries even while a rocket campaign proceeds normally. An acquired optical or communications business can add revenue before its systems, processes and cost base are fully integrated. These differences help explain why the group can report rapid revenue growth alongside cash consumption and a much smaller improvement in operating losses. Understanding the mix is the starting point for interpreting both the financial statements and the contract announcements.

03 What the Synspective agreement shows

Rocket Lab’s September 30, 2026 announcement describes an agreement for twenty additional Electron missions for Synspective, with launches from Launch Complex 1 into sun-synchronous orbit during 2028–2031. The company calls it its largest commercial Electron launch contract and says its overall launch backlog exceeds one hundred missions. The financial terms are undisclosed. Synspective’s own announcement, dated October 1 in Japan, independently confirms the schedule and says the relationship now covers forty-seven contracted launches, with thirteen completed and thirty-four still to fly. That makes Synspective the customer with the most Electron missions. Because the new launches are scheduled for 2028–2031, the agreement contributes no launch revenue in 2026 or 2027; its near-term relevance lies in the fourteen earlier-contracted missions still to fly (thirty-four remain in all, including the twenty new ones); the Synspective launches of September 2026 are among the thirteen already flown. Rocket Lab announcement Synspective announcement

The distinction between additional missions, lifetime contracted missions and remaining missions matters. The new order extends an existing customer programme; it is not a statement that every contracted mission is still outstanding. Nor does the company-wide mission count replace the dollar backlog disclosed in the quarterly accounts. A mission can differ in vehicle, customer requirements, integration work and timing. Counting them describes workload and customer commitment; it does not provide a uniform unit of revenue or profit.

For a constellation operator, dedicated launch can provide more control over orbital placement and deployment timing than sharing a larger vehicle’s schedule. That is consistent with Electron’s differentiated offering described in Rocket Lab’s annual report. For the supplier, a repeat commitment can improve forward production planning. Those advantages still depend on spacecraft readiness, launch reliability and the economics of the actual contract. The announcement does not disclose cancellation protection, deposits, escalation clauses or the margin Rocket Lab expects to earn. Annual report Rocket Lab announcement

There is consequently no sound basis for multiplying an old average launch price by the new mission count and presenting the result as the contract’s value. Rocket Lab’s quarterly revenue-per-launch measure reflects the missions flown in that period and their particular terms; it is not a published rate card for a multi-year agreement. Likewise, the future launch schedule does not justify increasing near-term revenue guidance without a company disclosure. The positive evidence is a larger committed relationship with a repeat customer. The financial value becomes clearer through subsequent reported backlog, contract performance and cash collections, rather than through an invented estimate attached to the announcement.

04 Electron and HASTE: flights, revenue and capacity

Launch activity and accounting revenue need to be read together. Rocket Lab completed six Electron launch missions in the quarter ended June 30, 2026, compared with five in the corresponding 2025 quarter, yet Launch Services revenue declined from $46.646 million to $44.586 million. The quarterly report explains that two of the recent missions were HASTE launches accounted for over time, with part of their revenue recognised in earlier quarters; all of the comparison period’s launches used point-in-time recognition. The segment also included other launch revenue from contract termination and studies. More flights therefore did not mechanically produce more quarterly revenue. Quarterly report

The operating metrics answer a different question. For the quarter ended June 30, 2026, Rocket Lab reported revenue per launch of $9.1 million and cost per launch of $4.4 million, compared with $7.9 million and $5.0 million in the prior-year quarter. Those measures reflect the contract value and costs of the missions included in the operating calculation. They should not be reverse-engineered simply by dividing reported segment revenue or cost by the number of flights. Customer mix, mission complexity and the timing of over-time recognition prevent that shortcut. Quarterly report

The flight record gives that analysis its context. Rocket Lab reported eighty-seven successful Electron missions through June 30, 2026, after twelve launches in the first half of the year. The third quarter added six more: missions for iQPS on August 6 (the ninety-second Electron launch) and August 20/21 (ninety-third); Synspective’s “Owl Around The World” on September 2/3 (ninety-fourth); a confidential mission named “Happily Ever Faster” on September 11 (ninety-fifth); and two further Synspective missions, “Owl By The Dozen” on September 19 (ninety-sixth) and “Owlright Owlright Owlright” on September 25 U.S. Eastern time, September 26 in New Zealand (ninety-seventh). That brought Electron, by September 26, to eighteen launches in 2026, all successful, and ninety-seven launches overall; the overall count includes the vehicle’s earlier unsuccessful flights, which is why it exceeds the count of successful missions. For comparison, Rocket Lab flew twenty-one launches in 2025, three of them HASTE missions. Results release Launch updates

Suborbital demand has also grown in contract terms. On March 18, 2026, Rocket Lab announced a $190 million agreement for twenty HASTE launches. On July 27 it announced what it called its largest launch contract to date, signed on July 21 under the U.S. Space Force’s Rocket Systems Launch Program: twelve HASTE launches plus options for up to six more, worth up to $266 million, to fly mostly from a new site at Kodiak, Alaska, with the first mission no earlier than the end of 2026. Earlier, on June 19 (New Zealand time), Electron flew the VICTUS HAZE responsive-space mission for the U.S. Space Force 16 hours and 42 minutes after Space Systems Command issued the notice to launch, according to Rocket Lab. One successful responsive demonstration does not by itself show a recurring revenue line. July 27 announcement Rocket Lab update

HASTE gives the company exposure to suborbital testing demand, including government programmes whose mission requirements differ from placing a commercial satellite into orbit. That can improve the usefulness of Electron-derived hardware across different customers, while making the revenue mix less uniform. It also introduces programme-specific milestones, customer dependencies and contract accounting. A successful suborbital test is just that; it does not count as an orbital satellite deployment.

Manufacturing and launch infrastructure both constrain throughput. Rocket Lab’s annual report describes its own New Zealand launch complex and access to facilities in Virginia, together with integrated production and testing capabilities. Launch Complex 1 in New Zealand is licensed for up to 120 launches a year; Launch Complex 2 at Wallops, Virginia, is licensed for eight a year; Launch Complex 3, also in Virginia, is under construction for Neutron and licensed for two launches a year; its readiness is tied to Neutron’s schedule; the first launch is now expected in 2027 (October 14, 2026 update). On August 10, 2026 the company added GHOST, a deployable launch system, and Launch Complex 4 at Kodiak, Alaska, with two pads and a suborbital debut planned for 2027. Control of a launch site can reduce scheduling conflicts with other providers, but theoretical site capacity is not demonstrated annual output. Vehicle production, payload readiness, regulatory approvals, range availability and weather still have to align. The annual risk disclosures also explain how a launch failure can halt subsequent operations while an investigation and authorisation process take place. Annual report

The useful operating evidence is therefore sustained delivery across successive campaigns, supported by appropriate manufacturing capacity and margins. A rising mission count with worsening working capital or repeated customer delays would be a weaker result than the headline suggests. Conversely, a quarter with lower recognised launch revenue can still contain operational progress when previously recognised missions are successfully completed. The filings make it possible to distinguish those cases without turning a launch broadcast into a financial conclusion.

05 Neutron: the difference between reaching the pad and operating a service

Neutron is intended to move Rocket Lab beyond Electron’s small-payload market. The annual and quarterly reports describe a reusable medium-lift design with a target capacity of approximately 13,000 kilograms to low Earth orbit in reusable configuration. That specification describes the planned vehicle, not a demonstrated commercial capability. Larger constellation deployments and government missions could expand the addressable launch business if the programme reaches operational service. Annual report Quarterly report

The timetable has moved during 2026. The annual report filed on February 26 targeted a first launch in the fourth quarter of 2026. The August 10, 2026 update instead speaks of delivering Neutron to the launch pad in the fourth quarter, with first-stage tank production aligned to that target, and the quarterly report ties the timing to “first stage qualification and other critical tests occurring later in 2026”, adding that the window for a launch before year-end is narrowing. On the results call the same day, management acknowledged that the debut could slip into 2027, as reported in the press (Source). On October 14, 2026 Rocket Lab announced that Neutron’s inaugural launch is now expected to occur in 2027, citing continued development and the incorporation of process improvements. Press release, October 14, 2026 Pad delivery, successful qualification, the first flight and a repeatable launch service are distinct milestones. Treating the pad target as a guaranteed orbital launch date removes the qualification risk that the company itself describes. Quarterly report Results release

There is a concrete reason to keep those stages separate. The annual report records a first-stage tank rupture during a hydrostatic qualification test on January 21, 2026, affecting the programme’s schedule; the company disclosed the event in a current report the same day. Testing is designed to expose limits before flight, but a test failure can still require redesign, replacement hardware and additional work. Progress in engines or fairings cannot by itself certify the complete vehicle. Interfaces between subsystems, ground equipment and launch operations also have to perform together. Other parts of the vehicle have advanced: Rocket Lab’s February 26 results release reported the fairing and the thrust structure as qualified, with the fairing delivered to Virginia. The August filings tied the first-flight timing to first-stage qualification and other critical tests, and on October 14, 2026 the first launch was moved to 2027; in Merlintrader’s assessment, an integrated static fire at Launch Complex 3 would be among the most demanding of them. Annual report January 21 filing

Neutron already has customers waiting, which raises both the value of success and the cost of delay. On May 7, 2026, Rocket Lab announced a contract with a confidential customer for five Neutron and three Electron launches between 2026 and 2029, described at the time as the largest launch contract in company history. On August 10, Kepler Communications booked a dedicated Neutron launch no earlier than 2028. The $397 million Space-Based Airborne Moving Target Indicator award discussed in section 08 also calls for its satellites to be launched on Neutron. These commitments are evidence of demand; they also mean that several customers’ schedules now depend on a vehicle that has not yet flown and whose first flight has moved to 2027. Results release SB-AMTI announcement

The commercial challenge extends beyond reaching orbit once. Rocket Lab would need reliable production, repeat launches, customer acceptance and an economically viable reuse process. A successful demonstration would reduce an important technical uncertainty while leaving questions about cost, turnaround time and achievable cadence. Until operational results establish those characteristics, assumptions about mature Neutron margins are scenarios rather than reported economics.

Development spending affects the current accounts before the new vehicle earns its expected revenue. Rocket Lab reported research and development expense of $82.429 million for the quarter ended June 30, 2026, with the filing identifying Neutron progress among the drivers alongside acquired-business spending and other products. The group does not disclose that entire line as Neutron-only expenditure. It would therefore be wrong to label all research spending as the cost of a single rocket or to assume it disappears after the maiden flight. Quarterly report

The strongest evidence of de-risking would connect engineering milestones to commercial readiness: completed qualification, a vehicle and site ready together, successful flight performance and then repeat execution. New contracts help establish demand. They cannot perform the engineering work or remove the cash requirements needed to satisfy that demand.

06 The latest quarter: growth, margins and the loss that remains

For the quarter ended June 30, 2026, revenue increased to $234.066 million from $144.498 million in the corresponding 2025 period. Gross profit rose to $84.576 million from $46.388 million, taking the reported gross margin from approximately 32.1% to 36.1%. The improvement was substantial at the gross-profit level, but operating expenses also rose: research and development reached $82.429 million and selling, general and administrative expense reached $59.661 million. Operating loss consequently improved only modestly, from $59.639 million to $57.514 million. Quarterly report

The sequential comparison is less uniformly positive than the annual growth headline. Subtracting the second-quarter figures from the six-month totals in the June 30, 2026 filing gives first-quarter revenue of $200.348 million and gross profit of $76.493 million, a calculated gross margin of approximately 38.2%. Second-quarter revenue was higher, but its gross margin was lower. The same calculation gives a first-quarter operating loss of $55.969 million, slightly smaller than the second-quarter loss. These are calculated comparisons using the same filing, not separate company guidance. Quarterly report

Net loss for the quarter ended June 30, 2026 was $49.258 million, against $66.414 million a year earlier. Below the operating line, interest income increased from $5.019 million to $16.486 million while interest expense declined from $7.390 million to $0.581 million. Higher cash balances and convertible-note conversions therefore contributed to the improvement in the bottom line. That does not diminish the revenue growth, but it prevents attributing the entire earnings improvement to better production economics. Quarterly report

Two adjustments shape how the quarter reads. First, the results release reports a non-GAAP gross margin of 41.5% for the quarter, against the 36.1% GAAP figure; the difference consists of items management excludes under its own definition. Second, acquisitions lift the headline growth rate. Reported revenue rose about 62% year on year, while the pro forma figures in the 10-Q’s acquisitions note, which present the acquired businesses as if they had been owned in both periods, show $237.8 million against $173.1 million, growth of roughly 37%. Stock-based compensation was $19.6 million in the quarter and $47.7 million in the first half; the half-year figure includes a one-time charge of $11.18 million linked to the restricted stock units that Peter Beck forfeited in March (section 13). Results release Quarterly report

The company’s adjusted EBITDA loss was $8.833 million for the quarter ended June 30, 2026, compared with $27.584 million a year earlier. Its reconciliation removes depreciation, amortisation, stock compensation, transaction costs and other specified items, while also removing interest income. The narrower adjusted loss is useful evidence under that definition; it is neither GAAP profitability nor cash generated by operations. In particular, excluding stock compensation does not remove its economic relevance to shareholders, and excluding transaction costs does not mean acquisition activity is free. Results reconciliation

For the third quarter of 2026, the August 10 release guided to revenue of $250–265 million, GAAP gross margin of 29–31% and an adjusted EBITDA loss of $17–23 million. The same outlook gave a non-GAAP gross margin of 35–37%, GAAP operating expenses of $143–149 million, net interest income of about $21 million, stock-based compensation of $18–20 million and approximately 641 million basic weighted-average shares, including about 41 million preferred shares. That outlook combined higher expected sales with lower expected margins and a larger adjusted loss than the second quarter. It describes management’s dated expectations, not reported third-quarter results. The appropriate comparison after the next release will include both revenue delivery and the costs required to achieve it. As of October 3, 2026, Rocket Lab had not announced the date of its third-quarter results. Results release

07 Revenue recognition and the estimates behind reported progress

Manufacturing revenue often arrives in the income statement before the final spacecraft is delivered or the last payment is collected. In the quarter ended June 30, 2026, Rocket Lab recognised $139.740 million of revenue over time, approximately 59.7% of total revenue calculated from the filing’s recognition table. Most of that came from Space Systems, although HASTE also contributed over-time launch revenue. This model reflects work performed on qualifying contracts and the progress measures specified by the accounting policy. It is not interchangeable with customer cash receipts. Quarterly report

Over-time recognition places weight on estimates of the work and cost needed to complete a contract. When those estimates change, previously recognised progress may need a cumulative adjustment. Rocket Lab reported $8.089 million of favourable revenue adjustments associated with previously satisfied performance obligations in the quarter ended June 30, 2026, including a $5.948 million favourable adjustment on one contract. Those disclosures help explain reported revenue and margins. They are not evidence of misconduct, but they do mean part of the quarter reflects revised estimates rather than only newly completed physical work. Quarterly report

The same mechanism can operate in the opposite direction. A fixed-price contract leaves the supplier exposed when labour, materials, qualification work or subcontractor costs exceed the assumptions used in pricing. Additional revenue is not automatic simply because completing the job becomes more expensive. The annual report identifies cost overruns and customer penalties as risks, and the quarterly report describes potential liquidated damages associated with delayed deliveries under the MDA spacecraft-bus contract. On August 16, 2026, platforms built for the MDA/Globalstar programme reached orbit, an operational milestone on that contract; it does not by itself quantify any damages or claims. It also identifies possible supplier claims; it does not provide a reliable net amount that can be inserted as an inevitable loss or recovery. Annual report Quarterly report

The balance-sheet counterpart matters. Contract assets of $94.245 million at June 30, 2026 represent recognised performance that has not yet become an unconditional receivable under the applicable terms. Accounts receivable were $112.889 million on the same date. They are different stages between work, billing and cash collection. A growing balance can accompany a growing business, but sustained increases without corresponding collections would weaken the quality of that growth. Quarterly report

Customer advances run in the other direction: cash can arrive before the related revenue is earned. However, not every increase in contract liabilities represents new customer cash. The June 30, 2026 quarterly note shows $76.015 million of contract liabilities assumed through acquisitions during the first half. Separating acquired obligations from cash movements is essential when assessing whether customers are financing production. Revenue, receivables, contract assets and contract liabilities together explain more than any single growth percentage. Quarterly report

08 Backlog, defense awards and what is actually committed

Rocket Lab reported backlog of $2.355949 billion at June 30, 2026, comprising approximately $1.4158 billion in Space Systems and $940.2 million in Launch Services. The company expected approximately 45% to be recognised over the following twelve months and the remainder later. Its definition includes enforceable agreements and excludes unexercised customer options. Backlog therefore provides visibility into contracted work, but does not equal cash in the bank or revenue guaranteed within the next quarter. Quarterly report

An earlier award helps explain why spacecraft execution carries so much weight. The 2025 annual report describes the December 17, 2025 SDA Tracking Layer Tranche 3 award for eighteen satellites, for a headline total of $816 million, comprising an $806 million base value and $10 million of options, with final delivery of the satellites for launch expected in 2029. The work extends beyond manufacturing to operations and sustainment. Those terms create a long production and delivery obligation, rather than an immediate cash receipt. They also distinguish the established government workload from later awards: the December contract belongs to the history supporting the reported backlog, whereas a July or September announcement requires its own reporting date. Annual report

The date is important because subsequent awards cannot be silently folded into that balance. The August 10, 2026 results release discusses contracts won after the quarter ended, including the Space Force’s Space-Based Airborne Moving Target Indicator programme. Its stated potential value of $397 million includes options, as indicated by the release’s footnote. The contract was signed on July 30 and announced on August 4, and the Flatellite spacecraft Rocket Lab is to build under it are to be launched on Neutron, which ties this award directly to the new rocket’s schedule. The suborbital contract signed on July 21 and announced on July 27, which Rocket Lab called its largest launch contract to date, comprises twelve HASTE launches for the Space Force’s Rocket Systems Launch Program plus options for up to six more, with a potential value of $266 million including options; most of those missions are to fly from a new site at Kodiak, Alaska, the first no earlier than the end of 2026. Firm work, optional work and maximum potential value are separate measures. Quarterly report Results release SB-AMTI announcement July 27 announcement

The rest of the 2026 award flow follows the same rule. Rocket Lab’s announcements this year include a $190 million agreement for twenty HASTE launches (March 18); its selection, together with Raytheon, by the U.S. Space Force to demonstrate capabilities for the Space Based Interceptor programme (May 7); a $90 million award for geostationary satellites (May 22); NASA’s selection of Rocket Lab for Sun and Earth science missions (June 25); three dedicated Electron missions for iQPS (July 30); a geostationary spacecraft bus for Viasat’s PTS-G programme (August 17); and the IMM Apex solar cell introduced on September 8. On August 10 the company said it had already signed more than $1 billion of new contracts in the third quarter; among its second-quarter and post-quarter highlights it listed more than $160 million for three geostationary satellites, a total that includes the May 22 Space Systems Command prime contract for two of them, and it added that its launch backlog exceeded ninety missions, a figure the September 30 Synspective announcement raised to more than one hundred. On August 17–18, Rocket Lab was onboarded to NITE-STAR, a multiple-award contract vehicle with a $981 million ceiling; that ceiling is shared among awardees and is not Rocket Lab’s contract value. None of these post-June awards is in the $2.356 billion June 30 backlog, and several are ceilings or include options. Results release Company updates

Not every contest has been won. On September 11, 2026, Rocket Lab protested NASA’s award of the $700 million Mars Telecommunications Orbiter contract to Blue Origin, as reported in the press (Source); a decision by the Government Accountability Office is expected around mid-December. A protest challenges an award made to someone else; it is not a contract, and its outcome could range from denial to a re-evaluation by NASA.

Government work can provide long programmes and technically demanding missions, but contract execution remains exposed to appropriations, programme priorities and termination provisions. Rocket Lab’s annual report explains the difference between termination for convenience and termination for default, as well as the risks of fixed-price work. Even where incurred costs are recoverable, the financial result may be less attractive than completing the original programme. Funding continuity and accepted performance are therefore part of the revenue analysis, rather than matters to consider only after a contract is cancelled. Annual report

Customer concentration amplifies these effects. The June 30, 2026 quarterly report identifies a single government customer that accounted for 42% of first-half revenue. The annual report uses a broader definition, combining U.S. government agencies, prime contractors and related subcontracts, under which that group represented 47% of 2025 revenue. The two percentages measure different populations and do not show a trend. The annual report also describes concentration in the largest backlog customers. A few significant programme changes can affect production planning, collections and future revenue even when the business serves many organisations overall. Diversification by product does not necessarily imply diversification by ultimate funding source. Quarterly report Annual report

For the commercial launch book, the Synspective commitment is evidence of repeat demand, but it remains linked to that customer’s spacecraft manufacturing, deployment schedule and financing capacity. The correct reading of backlog combines contract status, delivery timing, customer concentration and expected economics. The amount announced at signing is useful; the sequence from work performed to accepted delivery and cash collection determines how much value shareholders eventually receive.

09 Cash, working capital and why the balance grew

At June 30, 2026, Rocket Lab held $2.129485 billion in cash and equivalents, $172.700 million in current marketable securities and $85.405 million in non-current marketable securities. Their calculated total is $2.387590 billion, excluding restricted cash. That is a substantial liquidity base, but its source matters: during the first half of 2026, operating activities consumed $134.407 million, while at-the-market equity sales generated approximately $1.512917 billion in net cash proceeds. Cash accumulation was funded mainly through financing rather than internally generated operating cash. Quarterly report

Working capital explains much of the difference between the income statement and the cash-flow statement. During the six months ended June 30, 2026, inventory absorbed $73.331 million, accounts receivable absorbed $63.023 million and contract assets absorbed $30.057 million in the operating cash-flow reconciliation. Contract liabilities provided a partial offset of $78.835 million. Production expansion can create these needs before delivery and collection catch up; the same balances can become a problem if customer schedules slip or cost estimates deteriorate. The direction of subsequent collections is therefore an important test of the growth model. Quarterly report

Capital expenditure also has to be funded. Purchases of property, equipment and software were $53.112 million during the six months ended June 30, 2026. Subtracting that amount from operating cash flow gives a calculated cash deficit of $187.519 million before acquisitions and other investing or financing transactions. This simple cash-flow-minus-capex measure is not the company’s adjusted EBITDA and is not a complete forecast of future financing requirements. It highlights the resources consumed by running and building the existing business during that particular period. Quarterly report

An annualised runway calculation would be especially fragile here. Neutron development, milestone payments, customer advances, acquisitions and the pending Iridium transaction can change cash requirements materially. The quarterly filing’s statement that available resources should cover at least the following twelve months is management’s assessment under its assumptions, not a promise that spending remains constant. The September equity raise also occurred after the balance-sheet date and before a potentially large acquisition payment. Quarterly report September financing filing

Customer financing introduces a further collection risk. Rocket Lab’s June 30, 2026 balance sheet and notes identify approximately $32.150 million of current and non-current customer financing receivables in aggregate. These arrangements can help customers commit to launch programmes, but extend the path from contract award to cash. They are assets dependent on repayment, rather than unrestricted cash available to fund the next programme. Growth supported by such arrangements should be assessed alongside the customer’s ability to pay and the timing of principal and interest receipts. Quarterly report

10 Mynaric, Motiv and the cost of becoming more integrated

Rocket Lab completed the Mynaric acquisition on April 14, 2026, after German foreign direct investment approval on March 30, and the Motiv acquisition on May 26, 2026, following its acquisition of GEOST in August 2025. On February 26, 2026 it also announced that it had acquired two smaller businesses, Optical Support, Inc. and Precision Components Limited (Optical Support release; February 26 results release). The businesses add laser communications, robotics and optical capabilities to an already broad spacecraft and component portfolio. The strategic aim is to control more of the mission chain and offer customers integrated solutions. Their revenue contributions also change the comparison with periods when those businesses were outside the group. Quarterly report

In the quarter ended June 30, 2026, Mynaric contributed $13.195 million of revenue and an operating loss of $13.245 million after its acquisition date. Motiv contributed $1.420 million of revenue and an operating loss of $0.219 million. The figures show why adding technology and sales is not the same as adding immediate profitability. Integration, research investment, manufacturing performance and acquired intangible amortisation can all affect the result. The quarterly report’s hypothetical combined comparatives are presented separately from actual reported revenue; they are neither actual organic growth nor a forecast. Quarterly report

Integration at Mynaric is still being worked through. In its first partial quarter inside the group, the business reported an operating loss roughly equal to its revenue, and on September 24, 2026 its executive management was reorganised, with Andreas Reutter becoming chairman of the executive board. On August 10 Rocket Lab also announced Rocket Lab Germany GmbH. A management change at an acquired subsidiary is not evidence of failure, but it shows that integration remains an active process rather than a completed one. Quarterly report Results release

Purchase accounting requires similar care. For Motiv, the June 30, 2026 filing records consideration of $44.539 million, comprising $38.885 million of cash and $5.654 million of fair-valued contingent consideration. A possible future earnout is not necessarily paid at closing, and its accounting value is not necessarily the maximum contractual payout. For Mynaric, the accounting valuation reflects the measurement of shares issued and other elements at the acquisition date. Mixing a headline announcement value with a later accounting valuation can create an apparent discrepancy where the measurement basis has changed. Quarterly report

Goodwill and acquired intangible assets together also become more significant. At June 30, 2026, the balance sheet included $299.072 million of goodwill and $320.415 million of net intangible assets. These balances do not represent spare liquidity. They reflect value assigned to acquired capabilities and expected benefits, with amortisation or potential impairment affecting future accounts as applicable. The value of an acquisition ultimately depends on the cash flows the business can generate, not merely on the initial allocation of its purchase price. Quarterly report

There is a credible operational logic to securing critical components internally, especially where suppliers are specialised and programmes have long qualification cycles. There is also an organisational cost to absorbing additional facilities, staff, systems and customer obligations. Rocket Lab’s annual risk discussion expressly identifies integration difficulty and management distraction. The stronger outcome would combine better mission delivery with improving acquired-business economics; continuing losses and cash needs at those operations would weaken the argument that vertical integration alone guarantees attractive returns. Annual report

11 Iridium: the shareholder condition is cleared, the transaction is not closed

Under the merger agreement dated June 28, 2026, an Iridium share is entitled at closing to $27 in cash plus Rocket Lab shares under an exchange-ratio collar. The agreement specifies a ratio of 0.4000 at or below a defined Rocket Lab price of $67.50, a ratio calculated as $27 divided by that price between $67.50 and $112.50, and a ratio of 0.2400 at or above $112.50. The price is a specified volume-weighted average over ten consecutive trading days ending on the second full trading day before the first effective time. A single recent closing price does not determine the eventual exchange ratio. Merger filing Final prospectus

Applied to the share count, those terms give the order of magnitude. The cash portion comes to approximately $2.86 billion, calculated as $27 multiplied by 105,981,552 Iridium shares. The stock portion depends on the collar: at the October 2, 2026 close of $73.92, the ratio would be about 0.365, equivalent to approximately 38.7 million Rocket Lab shares, while at the maximum ratio of 0.4000, which applies at or below $67.50, it would be about 42.4 million shares. The prospectus estimates that former Iridium holders would hold approximately 4–6% of the voting power of the combined company. These are Merlintrader calculations at a single closing price, not the final terms, which depend on the averaging period before closing. Final prospectus

Iridium stockholders approved the agreement on September 24, 2026. Its filed voting results show 85,862,105 votes in favour, 318,415 against and 67,862 abstentions on the merger proposal. The filing continues to describe completion in mid-2027 as expected and subject to remaining closing conditions, including regulatory approvals. Approval by shareholders is a completed milestone; acquisition of the business is not. Iridium’s revenue, debt, subscribers and operating cash flow therefore are not yet consolidated in Rocket Lab’s reported June 2026 results. Iridium voting results

The FCC’s September 15, 2026 notice accepted the transfer applications for filing and established a comment process. It set October 15 for comments and petitions (that deadline has passed), October 30 for responses and November 9 for replies in GN Docket No. 26-257. Those are procedural deadlines, not scheduled approval dates. The notice describes Iridium’s communications authorisations and the proposed transfer, while attributing the claimed public benefits to the applicants. Acceptance for filing is not an endorsement of those arguments or consent to complete the transaction. FCC notice

Other conditions have moved as well. The waiting period under the Hart-Scott-Rodino Act expired on August 12, 2026, clearing the U.S. antitrust review. Still outstanding are FCC consent, which may involve a national-security review by the interagency group known as Team Telecom; certain foreign competition and investment approvals; and the review by the Defense Counterintelligence and Security Agency under the National Industrial Security Program rules (NISPOM). The merger agreement’s End Date is June 28, 2027, with two automatic three-month extensions available under its terms, and Iridium would owe Rocket Lab a $223.62 million termination fee in specified circumstances. A September 17 press report quoted Rocket Lab as on track to close by the second quarter of 2027; the filings themselves continue to say mid-2027. August 13 release Final prospectus Iridium voting results

Strategically, the transaction would add a service operator to a business already manufacturing and launching spacecraft. Recurring communications revenue could broaden the model beyond project-based hardware and launch contracts. It would also bring constellation investment, service reliability obligations, telecommunications regulation and a different operating organisation. Owning more stages of the supply chain can create opportunities, but does not automatically produce the cost savings or growth assumed in a transaction presentation. Integration benefits remain forecasts until operating evidence supports them.

The financial structure changes the risk as well. The September financing update says the cash payments expected for completion can be met through the financing arrangements and other available resources. It does not eliminate the need to allocate capital between the acquired operator, Neutron and the existing businesses. If the merger is delayed, expenditure and organisational attention can continue before the expected benefits arrive. If it closes, management must integrate the businesses while preserving customer service and delivering the standalone programmes already under way. September financing filing Quarterly report

12 Financing, dilution and the share count that a valuation needs

Rocket Lab’s September 15, 2026 filing reports approximately $1.944 billion of gross proceeds from the sale of approximately 29.3 million shares under its replacement August at-the-market programme, which ran from August 13 to September 15. Dividing gross proceeds by shares sold gives an implied average price of about $66.4. The filing does not disclose net proceeds; the sales agreement allows agent commissions of up to 2% of gross proceeds. The same filing says the $3.6 billion bridge commitment was terminated in full: the equity proceeds, together with the Iridium term loans allowed to stay in place, replaced it. Iridium’s lender consent permits approximately $1.775 billion of its term loans to remain outstanding after closing. That loan continuity helps avoid a refinancing requirement; it is not an additional cash deposit received by Rocket Lab. September financing filing

The amendment also changes obligations if the acquisition closes. The September 15 filing provides for a guarantee by Rocket Lab USA and a term-loan margin linked to Rocket Lab’s credit ratings, with the SOFR margin ranging from 2.50% to 3.00%. These are conditional post-closing financing terms. The original bridge is no longer available, and the historical ATM authorisations cannot be combined as unused capacity under the updated structure. The August programme replaced the remaining capacity of the earlier arrangement and the September disclosure reports proceeds actually raised. September financing filing August equity agreement

The September programme was the third equity programme of 2026. Under a $1 billion at-the-market programme in March, Rocket Lab sold 6.73 million shares for $474.0 million of gross proceeds. Under a $3 billion programme put in place in May, it sold 7.78 million shares for $1,055.6 million gross. The August agreement covered the unsold remainder of the May authorisation. Separately, collared forward transactions cover 7,451,200 shares and are expected to provide $474–642 million when they mature in April 2028, depending on the share price within the collar. Quarterly report August equity agreement

The reference price used on this page is the October 2, 2026 close of $73.92. A market value requires a share count that matches the intended economic scope and date. Rocket Lab’s quarterly cover reports 598,350,482 common shares outstanding on August 5, 2026, and the August 13 prospectus supplement for the at-the-market programme reports 598,459,739 as of August 7, 2026, the latest count reported in a filing. Both predate the September share sales. On Merlintrader calculations at the October 2 close, the August 7 count gives a market value of approximately $44.24 billion; adding the approximately 29.3 million shares sold through September 15 gives approximately $46.40 billion; also including the 40,951,250 Series A participating preferred shares gives approximately $49.43 billion. None of the three includes options, restricted stock units, forward contracts or Iridium merger shares. Market data August 13 prospectus supplement Quarterly report September financing filing

There is an additional distinction between common stock and participating preferred stock. At June 30, 2026, Rocket Lab had 598,180,438 common shares outstanding and 40,951,250 Series A convertible participating preferred shares. The preferred shares participate economically and are included in the earnings-per-share calculation on the applicable basis. Weighted-average shares used for quarterly earnings are not the same as shares outstanding on a particular date. Treasury shares, authorised shares, options, forwards and future merger consideration each require separate treatment. Quarterly report

Debt conversions also contributed to dilution before the September financing. The June 30, 2026 report states that $142.288 million of convertible-note principal converted into 27,760,779 common shares during the first half. Remaining principal was $13.366 million, equivalent to roughly 2.6 million shares on conversion, and holders of those 2029 notes could convert during the July 1–September 30, 2026 window; the much larger disclosed fair value of those notes is not their principal balance. The collared forward arrangements described above could provide future cash subject to settlement terms, but had provided no proceeds at June 30. A responsible valuation therefore needs an updated capitalisation table and a consistent treatment of financing instruments, rather than multiplying the latest price by whichever share count is easiest to find. Quarterly report

13 Governance, litigation and the limits of assurance

Rocket Lab remains led by founder, chief executive and chairman Sir Peter Beck. The annual report identifies dependence on his contribution as a business risk. The participating preferred structure also gives its holder specific governance rights, including director designation under its terms, rather than merely representing an ordinary economic stake. At June 30, 2026, the quarterly report describes the remaining preferred shares and conversion provisions. An insider percentage published by market-data sites and based only on listed common shares cannot substitute for understanding that structure. Annual report Quarterly report

Beck’s own pay changed in March. A current report filed on March 30, 2026 records that his base salary was reduced to $1 and his bonus waived, and that he forfeited 392,155 unvested restricted stock units. The change produced a one-time stock-based compensation charge of $11.18 million in the first half of 2026, so a reduction in pay appeared as a higher expense in the reported period. His economic alignment now rests on the common and preferred shares he holds through his trust, described below. March 30 filing

The finance organisation expanded in June 2026. The June 5 filing records Agostino Ricupati’s appointment as chief accounting officer and principal accounting officer effective June 3, while Adam Spice remains chief financial officer and principal financial officer. The role matters as acquisitions expand the number of systems, contracts and accounting judgements consolidated into the group. It does not by itself show better or worse reporting quality. In the June 30, 2026 quarterly report, management concluded that disclosure controls and procedures were effective. That conclusion is distinct from a guarantee that estimates will never change or acquired operations will never encounter difficulties. Appointment filing Quarterly report

The scope of the annual assurance matters as well. Management and the auditor excluded GEOST, acquired in August 2025, from their assessment of internal control over financial reporting at December 31, 2025; the annual report says GEOST represented approximately 14% of consolidated assets and 2% of annual revenue. The overall conclusion was that internal control was effective. The acquisition scope exclusion is neither a finding of a material weakness nor assurance that the excluded systems had already been fully tested. It puts the subsequent integration and quarterly disclosure-control conclusions in their proper context. Annual report

The litigation chronology also needs its latest outcome. The quarterly filing records dismissal with prejudice of the Neutron-related securities class action on April 16, 2026 and states that the plaintiffs did not appeal. It also records dismissal of the consolidated derivative action on May 28, 2026. Carrying the earlier annual report’s pending status forward would therefore give the wrong impression. Those dispositions concern the named proceedings; they are not a blanket declaration that the company can never face other contractual or transaction-related claims. Quarterly report

Insider-plan disclosures require similar precision, and the transaction filings now show what the plans have produced. Chief financial officer Adam Spice adopted a Rule 10b5-1 trading plan on June 3, 2026 covering up to 2,522,826 shares issuable on exercise of options. Under that plan he exercised options at $1.09 and sold 140,157 shares on September 2, 2026, for about $8.78 million at an average of about $62.63, and another 140,157 shares on October 1, 2026, for about $9.93 million at an average of about $70.82. After the October sale he held 1,155,967 shares directly. A plan’s maximum capacity is not evidence that every share will be sold, and a 10b5-1 plan is set in advance; the two filings so far show sales of identical size a month apart. Quarterly report Form 4, September Form 4, October 2

The largest insider transaction of the year came from the chief executive’s side. Peter Beck’s Equatorial Trust converted 5,000,000 Series A preferred shares into common stock on May 26, 2026 and sold 3,275,779 shares between July 6 and July 8, 2026, for about $286.4 million at an average of about $87.43, under a Rule 10b5-1 plan adopted on March 27, 2026. After those sales the trust reported 1,724,221 common shares and 40,951,250 preferred shares. In August, chief operating officer Frank Klein disposed of 81,250 shares, about $5.55 million in total — 35,558 sold under a Rule 10b5-1 plan and 45,692 sold to cover taxes on August 24 — and general counsel Arjun Kampani disposed of 13,788, of which 6,034 under a 10b5-1 plan and 7,754 to cover taxes; both plans date from September 19, 2025. The August 24 sell-to-cover sales involved five reporting persons — Spice, chief accounting officer Agostino Ricupati, Klein, Kampani and Clevenger — and relate to taxes on vesting awards, a sell-to-cover mechanism with a different purpose from discretionary sales. No officer or director bought shares in the open market in 2026. Planned sales by executives who retain large holdings are common in growth companies; they describe liquidity decisions, not a forecast of the business. Form 4, July

Ownership is concentrated in a few disclosed holders. Peter Beck reported 46,443,180 shares, or 7.51%, in a Schedule 13D/A filed on March 30, 2026, before the preferred conversion and July sales described above; VK Services, LLC and Vinod Khosla reported 34,888,272 shares, or 6.5%, in a 13D/A filed on February 17, 2026, an amendment that removed the Khosla Ventures entities as reporting persons; and Vanguard reported 30,080,579 shares, or 5.19%, in a Schedule 13G filed on July 31, 2026. Since June 22, 2026, following the June 12 announcement, the stock has been a member of the Nasdaq-100 index, which makes it a component of funds that track that index. Short interest reported by Nasdaq was 43,482,976 shares at the September 15 settlement date, with a days-to-cover ratio of 2.39, compared with 45,378,891 at August 31 and 42,599,639 at June 30. On approximately 627.8 million common shares after the September sales, that is about 6.9% of the common stock, a Merlintrader calculation. Short positions can reflect hedging as well as negative views, so the figure alone does not reveal intent.

The larger governance question is execution across a widening portfolio. Management must fund development, integrate acquired suppliers, deliver fixed-price programmes and pursue a major regulated transaction at the same time. Clear disclosures, consistent accounting and the ability to reconcile announcements with reported outcomes matter because each activity can consume resources before producing its intended return. Strong technical leadership is an asset; it does not replace the financial discipline needed to manage all those commitments together.

14 The evidence that would change the reading

The next financial report should show whether higher sales are translating into stronger operating performance and better cash conversion. The August 10, 2026 third-quarter outlook already anticipated a different margin profile from the June quarter, so revenue alone will not settle the question. Changes in contract estimates, acquired-business contributions, receivables, inventory and customer advances will help distinguish genuine operating improvement from timing and scope effects. The comparison rests on the distinction between GAAP results, management’s adjusted measures and actual cash movements. Results release Quarterly report

For Electron, further execution on committed missions would support the repeat-customer case. Contract cancellations, payload delays or a prolonged interruption would weaken it. For Space Systems, delivery acceptance and cash collection are more informative than treating every programme ceiling as immediately available revenue. For Neutron, in Merlintrader’s assessment, an integrated static fire at Launch Complex 3 is the next visible test, and completed qualification and demonstrated flight performance would reduce uncertainty; a change in the flight timetable, as announced on October 14, 2026, has to be evaluated together with cost and customer consequences, rather than through a date alone.

Iridium’s remaining dated procedural milestones under the FCC’s September 15, 2026 notice are October 30 for responses and November 9 for replies; the October 15 deadline for comments and petitions passed with letters from Ligado Networks and SpaceX but no filing classified as a petition to deny. Outside the Iridium process, the GAO decision on the Mars Telecommunications Orbiter protest is expected around mid-December. Completion remains a separate, conditional event under the September 24 voting filing. Regulatory conditions, integration planning and the financing consequences after closing should be followed together. The end of a comment period is not a regulatory decision, and completion is not assured merely because funding and shareholder consent have progressed. FCC notice Iridium voting results

The constructive interpretation would become stronger if Rocket Lab delivers the larger workload with improving cash economics and limited additional dilution. It would become weaker if revenue growth continues to require disproportionately more working capital, acquired operations absorb persistent losses, or development and integration obligations compete for the same resources. The Synspective order is evidence of commercial demand. The broader investment question is whether Rocket Lab can convert that demand and its expanding technical capabilities into durable earning power for the enlarged shareholder base. That remains an analytical question, not a recommendation to buy, sell or hold the shares.